Join us on Instagram Follow us on Facebook Join us on LinkedIn Follow us on Twitter Youtube Spotify Soundcloud
Menu Close

Join us on

Instagram Follow us on Facebook Join us on LinkedIn Follow us on Twitter Youtube Spotify Soundcloud
cerenovus embotrap Thrombectomy
The online reference source for the interventional NeuroRadiology, Neurology and NeuroSurgery community

The online reference source for the interventional NeuroRadiology, Neurology and NeuroSurgery community

Home >Sponsored Contents >The EMBOTRAP® experience and First Pass efficacy in mechanical thrombectomy

The EMBOTRAP® experience and First Pass efficacy in mechanical thrombectomy

What do you know about the “First Pass Concept” and the proven clinical results in the ARISE2 study? What are the implications for innovative stent retrievers like the EMBOTRAP®?

 

Join Osama Zaidat (USA) and Vincent Costalat (France) as they relive the recent LINNC Paris 2019 symposium dedicated to this exciting clinical idea and novel device. Learn why the EMBOTRAP® design allows for excellent results across the whole gamut of clot composition. Discover why using the EMBOTRAP® and the First Pass Concept helps push “the envelope further” in mechanical thrombectomy offering less manipulation of the vessel, less endothelial damage and a more complete reperfusion. Discover the first core lab adjudicated device with a first pass effect and why the French interventionists led by V. Costalat went from EMBOTRAP® sceptics to EMBOTRAP believers here…

 

This video was recorded at LINNC 2019 and is offered by CERENOVUS.

LECTURE

conference room 5:10:01 pm BEST CASES SUBMITTED BY ATTENDEES - Subacute intra-stent thrombosis treated with endovascular thrombectomy -AChoA stent o...

View

INTERVIEW

Ángel Chamorro interview - The CHOICE Randomized Clinical Trial

View

INTERVIEW

New Technologies for Stroke Treatment

View

CASE

10:10:00 am Thrombectomy in a tandem lesion: let's discuss the most optimal technique when you are faced with an RBC-rich clot! Is it worth the ris...

View

INTERVIEW

A solution for tough clot?

View